253 related articles for article (PubMed ID: 19789386)
1. In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia.
Calissano C; Damle RN; Hayes G; Murphy EJ; Hellerstein MK; Moreno C; Sison C; Kaufman MS; Kolitz JE; Allen SL; Rai KR; Chiorazzi N
Blood; 2009 Nov; 114(23):4832-42. PubMed ID: 19789386
[TBL] [Abstract][Full Text] [Related]
2. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.
Damle RN; Temburni S; Calissano C; Yancopoulos S; Banapour T; Sison C; Allen SL; Rai KR; Chiorazzi N
Blood; 2007 Nov; 110(9):3352-9. PubMed ID: 17684154
[TBL] [Abstract][Full Text] [Related]
3. Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cells.
Calissano C; Damle RN; Marsilio S; Yan XJ; Yancopoulos S; Hayes G; Emson C; Murphy EJ; Hellerstein MK; Sison C; Kaufman MS; Kolitz JE; Allen SL; Rai KR; Ivanovic I; Dozmorov IM; Roa S; Scharff MD; Li W; Chiorazzi N
Mol Med; 2011; 17(11-12):1374-82. PubMed ID: 21968788
[TBL] [Abstract][Full Text] [Related]
4. The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.
Chen L; Li J; Zheng W; Zhang Y; Wu Y; Li L; Qian S; Xu W
Leuk Lymphoma; 2007 Sep; 48(9):1785-92. PubMed ID: 17786715
[TBL] [Abstract][Full Text] [Related]
5. Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.
Brachtl G; Sahakyan K; Denk U; Girbl T; Alinger B; Hofbauer SW; Neureiter D; Hofbauer JP; Egle A; Greil R; Hartmann TN
PLoS One; 2011; 6(8):e23758. PubMed ID: 21876768
[TBL] [Abstract][Full Text] [Related]
6. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
[TBL] [Abstract][Full Text] [Related]
7. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
8. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.
Cutrona G; Colombo M; Matis S; Fabbi M; Spriano M; Callea V; Vigna E; Gentile M; Zupo S; Chiorazzi N; Morabito F; Ferrarini M
Haematologica; 2008 Mar; 93(3):413-22. PubMed ID: 18287138
[TBL] [Abstract][Full Text] [Related]
9. Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases.
Kroft SH; Dawson DB; McKenna RW
Am J Clin Pathol; 2001 Mar; 115(3):385-95. PubMed ID: 11242795
[TBL] [Abstract][Full Text] [Related]
10. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.
Dewald GW; Brockman SR; Paternoster SF; Bone ND; O'Fallon JR; Allmer C; James CD; Jelinek DF; Tschumper RC; Hanson CA; Pruthi RK; Witzig TE; Call TG; Kay NE
Br J Haematol; 2003 Apr; 121(2):287-95. PubMed ID: 12694251
[TBL] [Abstract][Full Text] [Related]
11. Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia.
Brezinova J; Berkova A; Vcelikova S; Zemanova Z; Izakova S; Sarova I; Cechova H; Tajtlova J; Grosova L; Lizcova L; Malinova E; Zemanova M; Cmunt E; Karban J; Trneny M; Schwarz J; Michalova K
Neoplasma; 2010; 57(3):215-21. PubMed ID: 20353271
[TBL] [Abstract][Full Text] [Related]
12. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells.
Deaglio S; Capobianco A; Bergui L; Dürig J; Morabito F; Dührsen U; Malavasi F
Blood; 2003 Sep; 102(6):2146-55. PubMed ID: 12763926
[TBL] [Abstract][Full Text] [Related]
13. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
[TBL] [Abstract][Full Text] [Related]
14. Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia.
Basabaeen AA; Abdelgader EA; BaHashwan OS; Babekir EA; Abdelateif NM; Bamusa SA; Abdelrahim SO; Altayeb OA; Fadul EA; Ibrahim IK
BMC Res Notes; 2019 May; 12(1):282. PubMed ID: 31122288
[TBL] [Abstract][Full Text] [Related]
15. Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome.
Bojarska-Junak A; Hus I; Sieklucka M; Wasik-Szczepanek E; Mazurkiewicz T; Polak P; Dmoszynska A; Rolinski J
Oncol Rep; 2010 Sep; 24(3):803-10. PubMed ID: 20664990
[TBL] [Abstract][Full Text] [Related]
16. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
Hulkkonen J; Vilpo L; Hurme M; Vilpo J
Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation.
Damle RN; Fais F; Ghiotto F; Valetto A; Albesiano E; Wasil T; Batliwalla FM; Allen SL; Schulman P; Vinciguerra VP; Rai KR; Gregersen PK; Ferrarini M; Chiorazzi N
Curr Top Microbiol Immunol; 2000; 252():285-92. PubMed ID: 11125486
[No Abstract] [Full Text] [Related]
19. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
[TBL] [Abstract][Full Text] [Related]
20. [Expression of CLLU1 in patients with chronic lymphocytic leukemia and its prognostic significance].
Chen LJ; Zheng WJ; Wu YJ; Li L; Qian SX; Xu W; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):737-40. PubMed ID: 18457263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
